Does Transparency Matter? The Impact of Provider Quality and Cost Information on Health Care Cost and Preventive Services Use

S. Parente, R. Feldman, Suzanna Lewis
{"title":"Does Transparency Matter? The Impact of Provider Quality and Cost Information on Health Care Cost and Preventive Services Use","authors":"S. Parente, R. Feldman, Suzanna Lewis","doi":"10.36648/2471-9927.5.1.44","DOIUrl":null,"url":null,"abstract":"Background: We tested whether provider quality and cost information had a meaningful impact on health care quality and costs at two large employers that introduced a transparent provider profiling system in 2006. Using retrospective claims from enrollees representing 3,928 covered lives in these two firms where the insurer was the sole provider of health insurance, we addressed two questions: 1) Did patients switch to higher quality and more efficient doctors when the provider rankings became available? 2) What is the effect of switching on total expenditures, out-of-pocket expenditures, and use of preventive services? Methods: We used nonlinear regression to identify factors associated with improvement in quality and cost efficiency of providers seen by covered enrollees. We used difference-in-differences regression to test the impact on expenditures and use of preventive services of those who switched to higher-rated physicians. Results: Age, illness burden, and female are positively associated with improvement in provider quality and efficiency. Provider portfolio improvement had a negative impact on expenditures, but the story with respect to prevention is mixed: preventive visits go up when the patient has an improved provider portfolio, but utilization of diagnostic screening procedures goes down. Conclusions: A common concern in medical markets is the lack of information for consumers to shop for health care. We find consumers exhibit behaviors that suggest they use such information when it is available and useful. These results suggest that consumers could process additional price and quality information to gain more value from their health insurance benefits.","PeriodicalId":92074,"journal":{"name":"Journal of health & medical economics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.36648/2471-9927.5.1.44","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of health & medical economics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36648/2471-9927.5.1.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: We tested whether provider quality and cost information had a meaningful impact on health care quality and costs at two large employers that introduced a transparent provider profiling system in 2006. Using retrospective claims from enrollees representing 3,928 covered lives in these two firms where the insurer was the sole provider of health insurance, we addressed two questions: 1) Did patients switch to higher quality and more efficient doctors when the provider rankings became available? 2) What is the effect of switching on total expenditures, out-of-pocket expenditures, and use of preventive services? Methods: We used nonlinear regression to identify factors associated with improvement in quality and cost efficiency of providers seen by covered enrollees. We used difference-in-differences regression to test the impact on expenditures and use of preventive services of those who switched to higher-rated physicians. Results: Age, illness burden, and female are positively associated with improvement in provider quality and efficiency. Provider portfolio improvement had a negative impact on expenditures, but the story with respect to prevention is mixed: preventive visits go up when the patient has an improved provider portfolio, but utilization of diagnostic screening procedures goes down. Conclusions: A common concern in medical markets is the lack of information for consumers to shop for health care. We find consumers exhibit behaviors that suggest they use such information when it is available and useful. These results suggest that consumers could process additional price and quality information to gain more value from their health insurance benefits.
透明度重要吗?提供者质量和成本信息对医疗保健成本和预防服务使用的影响
背景:我们测试了提供者质量和成本信息是否对2006年引入透明提供者分析系统的两家大型雇主的医疗质量和成本产生有意义的影响。在这两家公司中,保险公司是唯一提供医疗保险的公司,我们利用代表3928名投保人的回顾性索赔,解决了两个问题:1)当供应商排名可用时,患者是否会转向质量更高、效率更高的医生?2)转换对总支出、自付支出和预防服务使用的影响是什么?方法:我们使用非线性回归来确定与被覆盖的参保人所看到的提供者的质量和成本效率的改善相关的因素。我们使用差异中差异回归来测试那些转向高评级医生的人对支出和使用预防服务的影响。结果:年龄、疾病负担、女性与服务质量和效率的提高呈正相关。提供者组合的改善对支出产生了负面影响,但关于预防的情况好坏参半:当患者的提供者组合得到改善时,预防性就诊增加,但诊断筛查程序的利用率下降。结论:医疗市场普遍存在的问题是消费者在购买医疗保健产品时缺乏信息。我们发现消费者表现出的行为表明,当这些信息是可用的和有用的时候,他们会使用这些信息。这些结果表明,消费者可以处理额外的价格和质量信息,以从他们的健康保险福利中获得更多的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信